With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Journey to Re-envisioning Access to Health Data
James is a licensed carpenter, quantum scientist and health-tech entrepreneur who is motivated by solving novel transformative problems. First joining as a partner in his family carpentry business, he built houses for 9 years until his strong interest in quantum physics led him to the University of Toronto. There he studied Engineering Science, majoring in physics and completed his masters with top publications in physical review letters and APS Physics. During his PhD, James partnered with co-founder Derrick Chow to found Medchart on a mission to eliminate barriers to access and control of one’s health information after experiencing the pains of interacting with archaic health information systems while his father-in-law was ill. As CEO, he has successfully grown MEdchart across the USA and Canada and attracted world-class investors to accelerate growth. He continues to grow Medchart today and is on a mission to radically re-envision access to health data.
Please use the following link to register in advance of the webinar:
https://us02web.zoom.us/meeting/register/tZcvdu6grz0oHNdqyb2WDkaFw9f3JzdLyfV_